Literature DB >> 15593388

Effects of beta-Aescin on the expression of nuclear factor-kappaB and tumor necrosis factor-alpha after traumatic brain injury in rats.

Guo-min Xiao1, Jing Wei.   

Abstract

To investigate the inhibiting effect of beta-Aescin on nuclear factor-kappaB (NF-kappaB) activation and the expression of tumor necrosis factor-alpha (TNF-alpha) protein after traumatic brain injury (TBI) in the rat brain, 62 SD rats were subjected to lateral cortical impact injury caused by a free-falling object and divided randomly into four groups: (1) sham operated (Group A); (2) injured (Group B); (3) beta-Aescin treatment (Group C); (4) pyrrolidine dithocarbamate (PDTC) treatment (Group D). Beta-Aescin was administered in Group C and PDTC treated in Group D immediately after injury. A series of brain samples were obtained directly 6 h, 24 h and 3 d respectively after trauma in four groups. NF-kappaB activation was examined by Electrophoretic Mobility Shift Assay (EMSA); the levels of TNF-alpha protein were measured by radio-immunoassay (RIA); the water content of rat brain was measured and pathomorphological observation was carried out. NF-kappaB activation, the levels of TNF-alpha protein and the water content of rat brain were significantly increased (P<0.01) following TBI in rats. Compared with Group B, NF-kappaB activation (P<0.01), the levels of TNF-alpha protein (P<0.01) and the water content of brain (P<0.05) began to decrease obviously after injury in Groups C and D. Beta-Aescin could dramatically inhibit NF-kappaB activation and the expression of TNF-alpha protein in the rat brain, alleviate rat brain edema, and that could partially be the molecular mechanism by which beta-Aescin attenuates traumatic brain edema.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15593388      PMCID: PMC1390755          DOI: 10.1631/jzus.2005.B0028

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  13 in total

1.  Effects of tacrolimus on hemispheric water content and cerebrospinal fluid levels of glutamate, hypoxanthine, interleukin-6, and tumor necrosis factor-alpha following controlled cortical impact injury in rats.

Authors:  J F Stover; B Schöning; O W Sakowitz; C Woiciechowsky; A W Unterberg
Journal:  J Neurosurg       Date:  2001-05       Impact factor: 5.115

2.  Prolonged activation of NF-kappaB following traumatic brain injury in rats.

Authors:  M Nonaka; X H Chen; J E Pierce; M J Leoni; T K McIntosh; J A Wolf; D H Smith
Journal:  J Neurotrauma       Date:  1999-11       Impact factor: 5.269

3.  NF-kappa B: ten years after.

Authors:  P A Baeuerle; D Baltimore
Journal:  Cell       Date:  1996-10-04       Impact factor: 41.582

Review 4.  The NF-kappa B and I kappa B proteins: new discoveries and insights.

Authors:  A S Baldwin
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

5.  An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat.

Authors:  T J Connor; C Song; B E Leonard; Z Merali; H Anisman
Journal:  Neuroscience       Date:  1998-06       Impact factor: 3.590

6.  Antioxidant defense and free radical production in a rabbit model of kidney ischemia-reperfusion.

Authors:  C Franssen; J O Defraigne; O Detry; J Pincemail; C Deby; M Lamy
Journal:  Transplant Proc       Date:  1995-10       Impact factor: 1.066

7.  Effect of escin on adrenocorticotropin and corticosterone levels in rat plasma.

Authors:  S Hiai; H Yokoyama; H Oura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1981-02       Impact factor: 1.645

8.  Ibudilast suppresses TNFalpha production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS.

Authors:  A Suzumura; A Ito; M Yoshikawa; M Sawada
Journal:  Brain Res       Date:  1999-08-07       Impact factor: 3.252

9.  Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury.

Authors:  P G Sullivan; A J Bruce-Keller; A G Rabchevsky; S Christakos; D K Clair; M P Mattson; S W Scheff
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

Review 10.  Nuclear factor kappa B: important transcription factor and therapeutic target.

Authors:  J I Lee; G J Burckart
Journal:  J Clin Pharmacol       Date:  1998-11       Impact factor: 3.126

View more
  11 in total

1.  Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo.

Authors:  Yong-Wei Wang; Shuang-Jia Wang; Yi-Nan Zhou; Shang-Ha Pan; Bei Sun
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-24       Impact factor: 4.553

2.  Escin, a novel triterpene, mitigates chronic MPTP/p-induced dopaminergic toxicity by attenuating mitochondrial dysfunction, oxidative stress, and apoptosis.

Authors:  Govindasamy Pushpavathi Selvakumar; Thamilarasan Manivasagam; Karamkolly R Rekha; Richard L Jayaraj; Namasivayam Elangovan
Journal:  J Mol Neurosci       Date:  2014-05-02       Impact factor: 3.444

3.  Evaluation of the effect of polyphenol of escin compared with ibuprofen and dexamethasone in synoviocyte model for osteoarthritis: an in vitro study.

Authors:  Hossein Maghsoudi; Jamal Hallajzadeh; Mozhghan Rezaeipour
Journal:  Clin Rheumatol       Date:  2018-04-16       Impact factor: 2.980

4.  Beta-escin has potent anti-allergic efficacy and reduces allergic airway inflammation.

Authors:  Ines Lindner; Christiane Meier; Angelika Url; Hermann Unger; Andreas Grassauer; Eva Prieschl-Grassauer; Petra Doerfler
Journal:  BMC Immunol       Date:  2010-05-21       Impact factor: 3.615

5.  Potent anti-inflammatory agent escin does not affect the healing of tibia fracture and abdominal wound in an animal model.

Authors:  Leiming Zhang; Hongsheng Wang; Tian Wang; Na Jiang; Pengfei Yu; Feiyan Liu; Yating Chong; Fenghua Fu
Journal:  Exp Ther Med       Date:  2012-01-31       Impact factor: 2.447

6.  The Effect of Rutin on Experimental Traumatic Brain Injury and Edema in Rats.

Authors:  Sahin Yuceli; Gulce Naz Yazici; Renad Mammadov; Halis Suleyman; Mustafa Kaya; Selcuk Ozdogan
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

7.  Escin, a pentacyclic triterpene, chemosensitizes human tumor cells through inhibition of nuclear factor-kappaB signaling pathway.

Authors:  Kuzhuvelil B Harikumar; Bokyung Sung; Manoj K Pandey; Sushovan Guha; Sunil Krishnan; Bharat B Aggarwal
Journal:  Mol Pharmacol       Date:  2010-01-26       Impact factor: 4.436

8.  Protective Effect of Lutein/Zeaxanthin Isomers in Traumatic Brain Injury in Mice.

Authors:  Mehmet Yalcin Gunal; Ayse Arzu Sakul; Ahmet Burak Caglayan; Fusun Erten; Oznur Ece Durmaz Kursun; Ertugrul Kilic; Kazim Sahin
Journal:  Neurotox Res       Date:  2021-06-15       Impact factor: 3.911

Review 9.  The multiple facets of drug resistance: one history, different approaches.

Authors:  Evandro Luís Niero; Bianca Rocha-Sales; Camila Lauand; Beatriz Araujo Cortez; Marcelo Medina de Souza; Paula Rezende-Teixeira; Marcel Shiniti Urabayashi; Adam Arai Martens; Jorge Henrique Neves; Gláucia Maria Machado-Santelli
Journal:  J Exp Clin Cancer Res       Date:  2014-04-28

10.  Aescin and diosmin each alone or in low dose- combination ameliorate liver damage induced by carbon tetrachloride in rats.

Authors:  Sara Mahmmoud El-Dakhly; Abeer Abdallah Ali Salama; Soha Osama Mahmoud Hassanin; Noha Nazeeh Yassen; Alaaeldin Ahmed Hamza; Amr Amin
Journal:  BMC Res Notes       Date:  2020-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.